scispace - formally typeset
M

Mechele R. Lee

Researcher at Harris Interactive Inc.

Publications -  5
Citations -  282

Mechele R. Lee is an academic researcher from Harris Interactive Inc.. The author has contributed to research in topics: Promoter & Membrane transport protein. The author has an hindex of 5, co-authored 5 publications receiving 261 citations. Previous affiliations of Mechele R. Lee include University of Pittsburgh.

Papers
More filters
Journal ArticleDOI

Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample

TL;DR: It is important for physicians to carefully screen patients for changes in RLS Symptoms for as long as they are on dopamine agents, with particular attention paid to those patients who present with the most severe RLS symptoms prior to treatment initiation.
Journal ArticleDOI

Interleukin-6 (IL6) Genotype Is Associated With Fat-Free Mass in Men But Not Women

TL;DR: It is indicated that the IL6 G-174C polymorphism is significantly associated with FFM in men but not women and no significant genotype differences were observed in total body fat mass in either men or women.
Journal ArticleDOI

C174T polymorphism in the CNTF receptor gene is associated with fat-free mass in men and women.

TL;DR: The results indicate that the C174T polymorphism in exon 9 of CNTFR is significantly associated with FFM in men and women, with concomitant differences in muscular strength.
Journal ArticleDOI

Relationship of a 5-HT transporter functional polymorphism to 5-HT1A receptor binding in healthy women.

TL;DR: Relationship of a 5-HT transporter functional polymorphism to5-HT 1A receptor binding in healthy women is studied and it is found that the polymorphism is more closely related to EMT than to TSP in women with high levels of polypeptidemia.
Journal ArticleDOI

Impact of systemic lupus erythematosus on burden of illness and work productivity in the United States

TL;DR: Higher self-reported SLE disease severity was directly associated with experiencing more frequent and more severe symptoms as well as higher levels of lost work time and lost work productivity.